Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 1
2006 5
2007 2
2009 1
2010 1
2011 1
2012 1
2013 2
2014 1
2016 1
2017 3
2018 6
2019 8
2020 9
2021 9
2022 6
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.
Gocho Y, Liu J, Hu J, Yang W, Dharia NV, Zhang J, Shi H, Du G, John A, Lin TN, Hunt J, Huang X, Ju B, Rowland L, Shi L, Maxwell D, Smart B, Crews KR, Yang W, Hagiwara K, Zhang Y, Roberts K, Wang H, Jabbour E, Stock W, Eisfelder B, Paietta E, Newman S, Roti G, Litzow M, Easton J, Zhang J, Peng J, Chi H, Pounds S, Relling MV, Inaba H, Zhu X, Kornblau S, Pui CH, Konopleva M, Teachey D, Mullighan CG, Stegmaier K, Evans WE, Yu J, Yang JJ. Gocho Y, et al. Among authors: roti g. Nat Cancer. 2021 Mar;2(3):284-299. doi: 10.1038/s43018-020-00167-4. Epub 2021 Jan 21. Nat Cancer. 2021. PMID: 34151288 Free PMC article.
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D, La Starza R, Gorello P, Pellanera F, Kalender Atak Z, De Keersmaecker K, Pierini V, Harrison CJ, Arniani S, Moretti M, Testoni N, De Santis G, Roti G, Matteucci C, Bassan R, Vandenberghe P, Aerts S, Cools J, Bornhauser B, Bourquin JP, Piazza R, Mecucci C. Di Giacomo D, et al. Among authors: roti g. Blood. 2021 Sep 2;138(9):773-784. doi: 10.1182/blood.2020010510. Blood. 2021. PMID: 33876209 Free PMC article. Clinical Trial.
Targeting oncogenic Notch signaling with SERCA inhibitors.
Pagliaro L, Marchesini M, Roti G. Pagliaro L, et al. Among authors: roti g. J Hematol Oncol. 2021 Jan 6;14(1):8. doi: 10.1186/s13045-020-01015-9. J Hematol Oncol. 2021. PMID: 33407740 Free PMC article. Review.
Targeting Notch Trafficking and Processing in Cancers.
Pagliaro L, Sorrentino C, Roti G. Pagliaro L, et al. Among authors: roti g. Cells. 2020 Sep 29;9(10):2212. doi: 10.3390/cells9102212. Cells. 2020. PMID: 33003595 Free PMC article. Review.
Targeting NOTCH1 in hematopoietic malignancy.
Roti G, Stegmaier K. Roti G, et al. Crit Rev Oncog. 2011;16(1-2):103-15. doi: 10.1615/critrevoncog.v16.i1-2.100. Crit Rev Oncog. 2011. PMID: 22150311 Review.
New Approaches to Target T-ALL.
Roti G, Stegmaier K. Roti G, et al. Front Oncol. 2014 Jul 8;4:170. doi: 10.3389/fonc.2014.00170. eCollection 2014. Front Oncol. 2014. PMID: 25072021 Free PMC article. Review.
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.
Montanaro A, Kitara S, Cerretani E, Marchesini M, Rompietti C, Pagliaro L, Gherli A, Su A, Minchillo ML, Caputi M, Fioretzaki R, Lorusso B, Ross L, Alexe G, Masselli E, Marozzi M, Rizzi FMA, La Starza R, Mecucci C, Xiong Y, Jin J, Falco A, Knoechel B, Aversa F, Candini O, Quaini F, Sportoletti P, Stegmaier K, Roti G. Montanaro A, et al. Among authors: roti g. Cell Death Dis. 2022 Jun 17;13(6):551. doi: 10.1038/s41419-022-05002-5. Cell Death Dis. 2022. PMID: 35710782 Free PMC article.
58 results